Avalon GloboCare Business Summary

Avalon GloboCare Corp. (ALBT) operates as a commercial-stage healthcare and technology hybrid, generating revenue through a diversified model that includes laboratory service fees, real estate rental income, and a rapidly expanding Software-as-a-Service (SaaS) vertical. The company’s primary business segments are Laboratory Testing Services (MSO), which provides genetics-driven toxicology and wellness diagnostics; Real Property Operating, focused on medical-related facilities; and the newly formed Avalon Quantum AI, LLC. This AI division, established following the $19.5 million acquisition of RPM Interactive in late 2025, commercializes the "Catch-Up" generative AI platform for automated video infrastructure. Additionally, Avalon markets the FDA-registered KetoAir™ breathalyzer for metabolic health management. Within the micro-cap biotech and digital health landscape, Avalon competes with firms such as Rafael Holdings (RFL), Myriad Genetics (MYNZ), and MyMD Pharmaceuticals (MYMD), positioning itself as a high-tech pivot from traditional clinical services toward AI-integrated precision diagnostics. Avalon was co-founded by Wenzhao "Daniel" Lu and Dr. David Jin, the latter of whom resigned as CEO in November 2025. The current leadership team is headed by Interim CEO and COO Meng Li, who brings over 15 years of executive experience from global media giants WPP and GroupM, and Chief Financial Officer Luisa Ingargiola, a veteran finance executive with a pedigree of CFO roles at multiple Nasdaq-listed entities. The Board of Directors is chaired by Wenzhao Lu, a seasoned healthcare entrepreneur with extensive operations in China via the DaoPei Medical Group. Notable board members include Michael Mathews, the CEO of Aspen Group, Inc. who joined following the RPM acquisition, and Lead Independent Director Steven Sanders, a corporate securities expert. The company’s strategic direction is further supported by institutional backing from recent private placements aimed at scaling its AI-driven media and healthcare platforms.